The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
I remember being excited when I read about a new cancer treatment that had cured a terminally ill child and so made an investment in the company.
This was Scancell back in 2008-09 and the treatment is still in clinical trials now. I still hold the shares and am still excited by the company. Just saying. GLA
bottom_feeder,
'The Auction doesn't matter. As PIs we don't have access and its for the 'In-Traders' to manipulate and make their profits.'
Any serious trader has access to the auctions. I am a PI (large AVCT holding) and a trader and I have full access. GLA
Sorry the FT link didn't show you the full article. Just google it yourselves. It's the same £40m in my opinion.
'Corporate broker Peel Hunt has raised £112m in a flotation on the London stock market to capitalise on the boom in dealmaking and other corporate activity.
The fundraising on Aim, London’s junior market, values the small and mid-cap stock specialist at about £280m. About £40m has been taken in new capital, while selling shareholders are expected to make about £72m, leaving a free float of 40 per cent.
Peel Hunt said the money raised in the placing would be used to support the next phase of the company’s growth, including establishing a European presence and continuing its investment in technology, new products and services.
It added that “a significant portion” of the money raised for existing shareholders would be used to fund personal tax liabilities arising from the corporate restructuring needed ahead of the flotation.
The broker wants to open a European office for EU clients next year given difficulties providing full services to the region after Brexit. It has been majority-owned by employees, including staff and investors that led a buyout of the company from Belgian bank KBC more than a decade ago.'
Just a theory, I stopped worrying about that type of thing many moons ago.
If you look at the share price chart it doesn't look like somebody has been buying a large stake to me. GLA
That would be lovely but I doubt it's the case. I think more likely they have ended up with the placing shares at 10p.
'Peel Hunt said the money raised in the placing would be used to support the next phase of the company’s growth, including establishing a European presence and continuing its investment in technology, new products and services.'
I think the above statement means investing in their own business! They are currently offering shares at 10.75 which would still be a nice profit for them. GLA
https://www.ft.com/content/1be1a66a-aac4-4b0c-8962-330613d691b2
Like I said yesterday, the SP is not going up until PEEL has shifted however many they have, or they know something that isn't in the public domain. Currently offering 50k at 106. Maybe a couple of large buys will do it but there hasn't been any for a while. GLA
Exactly smee,
This was my thinking when reading the NIH news release. The RADx Tech program has up to $300 million to support the accelerated development of tests during COVID-19 and beyond. AS stated that it was the antibody that failed in our first attempt. The recent RADx study accepted that multiple mutations could affect diagnostic antibody recognition. It all adds up to Affimers being the ultimate long term solution in rapid antigen tests. GLA
https://www.nih.gov/news-events/news-releases/nih-funded-team-develops-method-identify-future-sars-cov-2-mutations-could-affect-rapid-antigen-test-performance
'While many variants of concern contain multiple mutations to the N protein, the study authors note that their method does not evaluate how multiple mutations could affect diagnostic antibody recognition, representing a limitation of the study.'
Am I remembering right that our AffiDX lateral flow targeted the S protein? GLA